Da David Liu
CIK: 0002054265
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EDSA
Edesa Biotech, Inc.
Director
Discretionary Trading P&L
Holdings
About Liu Da David
Liu Da David (SEC CIK 0002054265) files insider reports with the SEC as Director of Edesa Biotech, Inc. (EDSA).
Signal8 holds 3 ownership filings by Liu Da David (1 Form 3, 2 Form 4), filed between Feb 18, 2025 and May 29, 2026. Those filings report 2 transactions, from May 29, 2025 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Liu Da David's filings is in MARKHAM, A6.
Recent filings by Liu Da David
Other insiders filing for Edesa Biotech, Inc. (EDSA)
- Nijhawan Pardeep, Chief Executive Officer
- Marshall Patrick, Director
- MacDonald Sean Arthur, Director
- Chypyha Joan, Director
- Weiler Peter J., Chief Financial Officer
- Brooks Michael J, President